2023
DOI: 10.48048/tis.2023.5350
|View full text |Cite
|
Sign up to set email alerts
|

Flavonoids from Extract Butanol of Twigs Erythrina crista-galli Against the Breast Cancer Cell Line Within In Silico Method

Abstract: Breast cancer is one of the most serious health problems in the world. The common treatments for breast cancer have side effects and resistance, so the search for cancer drugs from natural products that are more effective is still a concern for researchers. Flavonoids from Erythrina crista-galli, which is one of the natural products, have the potential as anticancer drugs based on their phytoestrogen activity that has been reported. The aim of this research is to isolate flavonoids from extract butanol of E. c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 34 publications
(48 reference statements)
0
1
0
Order By: Relevance
“…Polyphenolic metabolites isolated from E. crista-galli L. could interact with Arg394, Glu353, and His524 residues of the human estrogen receptor R (ERR), thus revealing a promising phytoestrogenic activity (Ashmawy et al, 2016). Moreover, diprenylgenistein and phaseollin isolated from the twigs of E. crista-galli L. showed the highest binding affinity towards CDK2 protein, revealing its anticancer activity (Imanuddin et al, 2023). Cyclin-dependent kinases (CDKs) are proteins that regulate the transition of cell cycle phases.…”
Section: In Silico Studymentioning
confidence: 99%
“…Polyphenolic metabolites isolated from E. crista-galli L. could interact with Arg394, Glu353, and His524 residues of the human estrogen receptor R (ERR), thus revealing a promising phytoestrogenic activity (Ashmawy et al, 2016). Moreover, diprenylgenistein and phaseollin isolated from the twigs of E. crista-galli L. showed the highest binding affinity towards CDK2 protein, revealing its anticancer activity (Imanuddin et al, 2023). Cyclin-dependent kinases (CDKs) are proteins that regulate the transition of cell cycle phases.…”
Section: In Silico Studymentioning
confidence: 99%